“A Preliminary Study on the Prognostic Significance of Cysteine-Rich EGF Ligand Domain 2 Protein (CRELD2) in Patients With Triple Negative Breast Cancer”. 2025. Biomolecules and Biomedicine 25 (7): 1663–1671. https://doi.org/10.17305/bb.2024.11865.